# Blood Pressure Reduction in Heart Failure

> **NCT01255475** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 21 (actual)

## Conditions studied

- Heart Failure
- Cardiac Failure
- Congestive Heart Failure

## Interventions

- **DRUG:** Hydralazine/amlodipine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01255475
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-10
- **Final completion:** 2013-01
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2014-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01255475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01255475, "Blood Pressure Reduction in Heart Failure". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01255475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*